| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | CA2368370C The use of dienogest in high dosages |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/02/2008 | WO2008051532A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008049931A1 Peptide extended insulins |
| 05/02/2008 | WO2008049711A1 Peptide extended insulins |
| 05/02/2008 | WO2007131737A3 Medication against breast cancer and related diseases |
| 05/02/2008 | CA2667007A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103120 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/01/2008 | US20080103119 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915391A1 Sra binding protein |
| 04/30/2008 | EP1915179A2 Human growth hormone conjugated with biocompatible polymer |
| 04/30/2008 | EP1915149A2 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 04/30/2008 | EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 04/30/2008 | EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | DE102006050558A1 Transdermal patch for administering norelgestromin has a matrix layer comprising norelgestromin, a silicone and diethylene glycol monoethyl ether, butanediol or propylene glycol |
| 04/30/2008 | CN101171234A Dihydropyridine derivatives |
| 04/30/2008 | CN101167699A Insulin sustained-release oral preparation and preparation method thereof |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384867C Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7364722 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 04/29/2008 | CA2266416C Insulin c-peptides |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2007118717A3 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/23/2008 | EP1914553A1 Method for identifying women with an increased risk of foetal growth retardation |
| 04/23/2008 | EP1913941A1 Polymorphic forms and solvates of Cinacalcet hydrochloride |
| 04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | CN101166736A Polymorph form II of tanaproget |
| 04/23/2008 | CN101166718A Androgen modulators |
| 04/23/2008 | CN101164618A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN100383130C Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome. |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361645 Androgenic 7-substituted 11-halogen steroids |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2318349C Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/22/2008 | CA2150642C Tablet, capsule, or granule comprising desogestrel |
| 04/17/2008 | WO2008044033A1 Amide derivatives |
| 04/17/2008 | WO2008043789A1 Novel compounds |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090804 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090754 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; zinc; stabilized against denaturing when in contact with an organic solvent |
| 04/17/2008 | US20080089946 Synergistic Phytoceutical Compositions |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1910402A2 3-ester prodrugs of estradiol |
| 04/16/2008 | EP1910401A2 3-ester prodrugs of ethynylestradiol |
| 04/16/2008 | EP1909835A1 Methods and compositions for treating female infertility using clomiphene |
| 04/16/2008 | EP1909825A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
| 04/16/2008 | EP1909785A2 Use of progesterone receptor modulators |
| 04/16/2008 | EP1789408B1 Androgen modulators |
| 04/16/2008 | EP1578727B1 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1349559B1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 04/16/2008 | CN101163505A Method of treatment using gh antagonist and somatostatin agonist |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/15/2008 | CA2200754C Process of making dosage units by wet granulation |
| 04/10/2008 | WO2008042362A1 Arylamino-arylpropanolamine derivatives and methods of their use |
| 04/10/2008 | WO2007141306A3 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |
| 04/10/2008 | WO2007140917A3 CRYSTALLINE FORMS OF 11 ß-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17- HYDROXY-19-NOR-17α-PREGNA-4,9-DIEN-3-ONE |
| 04/10/2008 | WO2007137874A3 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 04/10/2008 | WO2006065968A3 The uses of estrogen beta agonists to treat cognitive diseases |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1907394A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 04/09/2008 | EP1907004A2 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 04/09/2008 | EP1906960A1 New combination 1 |
| 04/09/2008 | EP1748770B1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | CN101160290A 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 04/09/2008 | CN101157725A Preparation method of human insulin analogue and usage thereof |
| 04/09/2008 | CN101156946A Application of antihypelipidemic medicine, hydrochloric acid racemic anisodamine, vitamine B**, nerve growth factor in the preparation of combination medicine for treating diabetes |
| 04/09/2008 | CN101156931A A Chinese medicine composition for vanishing sputum and dispelling knot |
| 04/09/2008 | CN101156927A A hyperthyroidism Tablet and its production technology |